Literature DB >> 19686529

The potential role of snus in tobacco harm reduction.

Coral Gartner1, Wayne Hall.   

Abstract

Entities:  

Mesh:

Year:  2009        PMID: 19686529     DOI: 10.1111/j.1360-0443.2009.02706.x

Source DB:  PubMed          Journal:  Addiction        ISSN: 0965-2140            Impact factor:   6.526


× No keyword cloud information.
  6 in total

1.  The Effect of Comparatively-Framed versus Similarity-Framed E-Cigarette and Snus Print Ads on Young Adults' Ad and Product Perceptions.

Authors:  Smita C Banerjee; Kathryn Greene; Yuelin Li; Jamie S Ostroff
Journal:  Tob Regul Sci       Date:  2016-07

Review 2.  Non-cigarette tobacco and the lung.

Authors:  Michael Schivo; Mark V Avdalovic; Susan Murin
Journal:  Clin Rev Allergy Immunol       Date:  2014-02       Impact factor: 8.667

3.  Real-World Evidence of Differences in Biomarkers of Exposure to Select Harmful and Potentially Harmful Constituents and Biomarkers of Potential Harm Between Adult E-Vapor Users and Adult Cigarette Smokers.

Authors:  Douglas Oliveri; Qiwei Liang; Mohamadi Sarkar
Journal:  Nicotine Tob Res       Date:  2020-06-12       Impact factor: 4.244

4.  Characterization of the Abuse Potential in Adult Smokers of a Novel Oral Tobacco Product Relative to Combustible Cigarettes and Nicotine Polacrilex Gum.

Authors:  Jianmin Liu; Jingzhu Wang; Andrea Vansickel; Jeffery Edmiston; Donald Graff; Mohamadi Sarkar
Journal:  Clin Pharmacol Drug Dev       Date:  2021-01-27

5.  Differences in Levels of Biomarkers of Potential Harm Among Users of a Heat-Not-Burn Tobacco Product, Cigarette Smokers, and Never-Smokers in Japan: A Post-Marketing Observational Study.

Authors:  Chikako Sakaguchi; Yasufumi Nagata; Akira Kikuchi; Yuki Takeshige; Naoki Minami
Journal:  Nicotine Tob Res       Date:  2021-06-08       Impact factor: 4.244

6.  Ending versus controlling versus employing addiction in the tobacco-caused disease endgame: moral psychological perspectives.

Authors:  Lynn T Kozlowski
Journal:  Tob Control       Date:  2013-05       Impact factor: 7.552

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.